212 related articles for article (PubMed ID: 11075869)
21. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
[TBL] [Abstract][Full Text] [Related]
22. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
23. Risk of contralateral breast cancer: associations with factors related to initial breast cancer.
Horn PL; Thompson WD
Am J Epidemiol; 1988 Aug; 128(2):309-23. PubMed ID: 3394698
[TBL] [Abstract][Full Text] [Related]
24. A case of quadruple primary malignancies including breast, tongue, and thyroid cancers and osteosarcoma in a young female without karyotype abnormality.
Kousaka J; Fujii K; Yorozuya K; Mouri Y; Yoshida M; Nakano S; Fukutomi T; Takahashi E; Yokoi T
Breast Cancer; 2014 Jul; 21(4):500-3. PubMed ID: 21562838
[TBL] [Abstract][Full Text] [Related]
25. The development of breast carcinoma in women with thyroid carcinoma.
Chen AY; Levy L; Goepfert H; Brown BW; Spitz MR; Vassilopoulou-Sellin R
Cancer; 2001 Jul; 92(2):225-31. PubMed ID: 11466673
[TBL] [Abstract][Full Text] [Related]
26. Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer.
McTiernan A; Weiss NS; Daling JR
Cancer Res; 1987 Jan; 47(1):292-5. PubMed ID: 3791213
[TBL] [Abstract][Full Text] [Related]
27. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones.
La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E
Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164
[TBL] [Abstract][Full Text] [Related]
28. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States).
Cook LS; White E; Schwartz SM; McKnight B; Daling JR; Weiss NS
Cancer Causes Control; 1996 May; 7(3):382-90. PubMed ID: 8734833
[TBL] [Abstract][Full Text] [Related]
29. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
McTiernan AM; Weiss NS; Daling JR
Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
[TBL] [Abstract][Full Text] [Related]
30. The risk of multiple primary breast and thyroid carcinomas.
Adjadj E; Rubino C; Shamsaldim A; Lê MG; Schlumberger M; de Vathaire F
Cancer; 2003 Sep; 98(6):1309-17. PubMed ID: 12973856
[TBL] [Abstract][Full Text] [Related]
31. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales.
Waller M; Moss S; Watson J; Møller H
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2257-61. PubMed ID: 18006913
[TBL] [Abstract][Full Text] [Related]
32. [Hormone replacement therapy in menopause and risk of breast cancer].
Clavel-Chapelon F; Hill C
Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
[TBL] [Abstract][Full Text] [Related]
33. Second cancer following cancer of the breast in Connecticut, 1935-82.
Harvey EB; Brinton LA
Natl Cancer Inst Monogr; 1985 Dec; 68():99-112. PubMed ID: 4088315
[TBL] [Abstract][Full Text] [Related]
34. Incidence of right-sided colorectal cancer after breast cancer: a population-based study.
Tang LY; Nugent Z; Demers AA; Singh H
Am J Gastroenterol; 2009 May; 104(5):1213-20. PubMed ID: 19319130
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract][Full Text] [Related]
36. Assisted reproductive technology use and outcomes among women with a history of cancer.
Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
[TBL] [Abstract][Full Text] [Related]
37. Impact of radiation therapy and/or chemotherapy on the risk for a second malignancy after breast cancer.
Lavey RS; Eby NL; Prosnitz LR
Cancer; 1990 Sep; 66(5):874-81. PubMed ID: 2386915
[TBL] [Abstract][Full Text] [Related]
38. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Gao X; Fisher SG; Emami B
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer risk and radiation dose among women treated for breast cancer.
Inskip PD; Stovall M; Flannery JT
J Natl Cancer Inst; 1994 Jul; 86(13):983-8. PubMed ID: 8007020
[TBL] [Abstract][Full Text] [Related]
40. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
